| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |